Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

526.53
Delayed Data
As of Jun 22
 +4.51 / +0.86%
Today’s Change
325.35
Today|||52-Week Range
543.55
+43.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues2.1B2.8B4.1B4.9B
 
 
 
 
 
Cost of Goods Sold155.4M205.0M392.7M299.7M
 
 
 
 
 
Depreciation And Amortization41.2M52.7M74.9M104.7M
 
 
 
 
 
 
Operating ExpensesGross Income1.9B2.6B3.6B4.5B
 
 
 
 
 
General Expenses1.1B1.7B2.4B3.1B
 
 
 
 
 
Research And Development818.7M1.2B1.5B1.9B
 
 
 
 
 
Total Operating Expenses1.3B2.0B2.9B3.5B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income760.5M838.4M1.3B1.3B
 
 
 
 
 
Extraordinary Credit0.001.2M0.000.00
 
 
Extraordinary Charge-2.9M-33.5M-18.9M-9.8M
 
 
 
 
 
Interest Expense On Debt48.3M43.6M14.2M7.2M
 
 
 
 
 
Other Expenses-499.0K1.2M0.0016.1M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income713.4M775.7M1.2B1.3B
 
 
 
 
 
Income Taxes-289.0M-427.7M-589.0M-434.3M
 
 
 
 
 
Net Income424.4M348.1M636.1M895.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS97.9M100.6M103.1M104.7M
 
 
 
 
 
Shares To Calculate EPS Diluted111.3M113.4M115.2M116.4M
 
 
 
 
 
 
Earnings Per ShareEPS$3.81$3.07$5.52$7.70
 
 
 
 
 
EPS Diluted$3.81$3.07$5.52$7.70